Ligand profile
H3P
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_05433 — Enoyl-[acyl-carrier-protein] reductase [NADH]
Identifiers
Database identifiers and provenance.
- Ligand ID
H3P- UniProt (similar protein)
P0AEK4- Target protein
- KP13_05433
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 40.5
- −1 ≤ LogP ≤ 5 6.61
- MW ≤ 500 Da 406.9
- LogP ≤ 5 6.61
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 40.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1c(c(c(c(c1Cl)Cl)Cc2c(c(cc(c2Cl)Cl)Cl)O)O)Clc1c(c(c(c(c1Cl)Cl)Cc2c(c(cc(c2Cl)Cl)Cl)O)O)Cl
InChI=1S/C13H6Cl6O2/c14-6-2-8(16)12(20)4(10(6)18)1-5-11(19)7(15)3-9(17)13(5)21/h2-3,20-21H,1H2InChI=1S/C13H6Cl6O2/c14-6-2-8(16)12(20)4(10(6)18)1-5-11(19)7(15)3-9(17)13(5)21/h2-3,20-21H,1H2
ACGUYXCXAPNIKK-UHFFFAOYSA-NACGUYXCXAPNIKK-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Mechanism
- Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor
- Binding sites
- PF13561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- UniProt UniProt P0AEK4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “H3P”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05433.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 59
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).